R-CHOP, followed by high dose therapy and autologous stem cell rescue (HDT/ASCR), and R-HyperCVAD have equivalent progression-free survival and are superior to R-CHOP alone in younger patients with mantle cell Lymphoma: A comparative effectiveness analysis from the National Comprehensive Cancer Network (NCCN) non-Hodgkin's lymphoma Outcomes Database project Meeting Abstract


Authors: LaCasce, A.; Vandergrift, J. L.; Rodriguez, M. A.; Crosby, A. L.; Lepisto, E. M.; Czuczman, M. S.; Nademanee, A. P.; Blayney, D. W.; Gordon, L. I.; Millenson, M.; Vanderplas, A.; Abel, G. A.; Zelenetz, A. D.; Friedberg, J. W.
Abstract Title: R-CHOP, followed by high dose therapy and autologous stem cell rescue (HDT/ASCR), and R-HyperCVAD have equivalent progression-free survival and are superior to R-CHOP alone in younger patients with mantle cell Lymphoma: A comparative effectiveness analysis from the National Comprehensive Cancer Network (NCCN) non-Hodgkin's lymphoma Outcomes Database project
Meeting Title: 51st Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 114
Issue: 22
Meeting Dates: 2009 Dec 5-8
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2009-11-20
Start Page: 167
End Page: 168
Language: English
ACCESSION: WOS:000272725800404
PROVIDER: wos
PUBMED: 22276299
DOI: 10.1182/blood.V114.22.403.403
Notes: Meeting Abstract: 403 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Zelenetz
    767 Zelenetz